Ortec Announces Claims Approval

Ortec International Inc. has announced that the US Patent and Trademark Office (USPTO) has approved claims for the second patent application of its Haptides technology platform. "This represents the second patent to be granted in the US covering the Haptides technology, a versatile technology which we believe can improve the efficacy of an array of current biomaterials in the market place today. We are actively pursuing licensing opportunities with this proprietary peptide with companies focused on the orthopedic, dental, and cosmetic markets, and we believe the newly granted claims further enhance Haptides’ potential value,” commented Ortec's Vice Chairman and CEO Ron Lipstein.
More in Companies